| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000010456 |
| Receipt No. | R000012180 |
| Official scientific title of the study | The adjunct analgesic effect of metoclopramide for the intraoperative caesarean section patients by combined spinal epidural anesthesia (CSEA). |
| Date of disclosure of the study information | 2013/04/10 |
| Last modified on | 2016/10/13 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | The adjunct analgesic effect of metoclopramide for the intraoperative caesarean section patients by combined spinal epidural anesthesia (CSEA). | |
| Title of the study (Brief title) | The adjunct analgesic effect of metoclopramide for the intraoperative caesarean section patients by combined spinal epidural anesthesia (CSEA). | |
| Region |
|
|
| Condition | ||
| Condition | Women being to undergo elective caesarean section by combined spinal epidural anesthesia. | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Testing metoclopramide injected preemptively as an analgesic adjunct for intraoperative caesarean section patients. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The presence or absence of pain in intraoperative patients. In the case of pain, the time from starting spinal anesthesia to appearance of the pain, degree of the pain (Numeric Rating Scale: 0~10), anesthetic level checked by using ice. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | YES |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Immediately after fetus delivery, we give normal saline (2ml) intravenously. | |
| Interventions/Control_2 | Immediately after fetus delivery, we give metoclopramide (10mg/2ml) intravenously. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | ASA physical status 1 or 2, women being to undergo elective caesarean section by combined spinal epidural anesthesia. | |||
| Key exclusion criteria | Asthma.
Hyper obesity (BMI over 35). ASA physical status 3 or higher. Other additional operations except tubal ligation. Operation more than 2 hours. Using a sadative agent or an additional analgesic agent before appearance of pain. Using metoclopramide before appearance of pain in normal saline group. |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Otoya Yoshimoto |
| Organization | Kagoshima city hospital |
| Division name | Department of anesthesiology |
| Address | 20-17,Kajiya-cho,Kagoshima-shi,Kagosima,Japan |
| TEL | 099-224-2101 |
| oyoshi-kago@umin.org | |
| Public contact | |
| Name of contact person | Otoya Yoshimoto |
| Organization | Kagoshima city hospital |
| Division name | Department of anesthesiology |
| Address | 20-17,Kajiya-cho,Kagoshima-shi,Kagosima,Japan |
| TEL | 099-224-2101 |
| Homepage URL | |
| oyoshi-kago@umin.org | |
| Sponsor | |
| Institute | Department of anesthesiology, Kagoshima city hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000012180 |